Inclusion of pregnant women in live vaccine trials is an ethical imperative.
The nearly universal fetal, neonatal and maternal mortality associated with Ebola infections in pregnancy necessitates development of a strategy to improve perinatal outcomes. Immunization of pregnant women with live-attenuated vaccines usually is contraindicated because of theoretical concerns of fetal damage via transplacental acquisition of the virus. Although there has been a pervasive presumption of exclusion of pregnant women in live vaccine trials and clinical initiatives, inclusion of these women is an ethical imperative in the setting of this devastating disease.
This activity is supported by an educational grant from Indivior, Inc.
See related story »
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2018 Healio All Rights Reserved.